Compass Therapeutics Inc. (CMPX): Price and Financial Metrics
CMPX Price/Volume Stats
| Current price | $2.60 | 52-week high | $2.70 |
| Prev. close | $2.50 | 52-week low | $0.76 |
| Day low | $2.34 | Volume | 1,403,100 |
| Day high | $2.64 | Avg. volume | 3,665,845 |
| 50-day MA | $1.64 | Dividend yield | N/A |
| 200-day MA | $1.48 | Market Cap | 357.73M |
CMPX Stock Price Chart Interactive Chart >
Compass Therapeutics Inc. (CMPX) Company Bio
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel bispecific targeting PD-1 and PD-L1, and a portfolio of bispecific and monoclonal antibodies at various stages of pre-clinical development. The company was founded by Thomas J. Schuetz on March 20, 2018 and is headquartered in Boston, MA.
CMPX Price Returns
| 1-mo | 88.41% |
| 3-mo | 45.25% |
| 6-mo | 147.62% |
| 1-year | 79.31% |
| 3-year | 7.44% |
| 5-year | N/A |
| YTD | 79.31% |
| 2024 | -7.05% |
| 2023 | -68.99% |
| 2022 | 58.68% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...